• Polomar Health Services, Altanine agreed on May 11, 2026 to waive multiple closing conditions tied to their July 23, 2025 merger agreement, amended Oct. 8, 2025, clearing remaining steps toward closing.
• Waived items include effectiveness of Altanine’s S-4 registration statement, approval of Nasdaq listing application, completion of a concurrent financing, execution of an equity credit line of at least USD 25 million, and a reverse stock split targeting a USD 10 share price.
• Parties also rewrote a merger-agreement provision to require delivery of updated PCAOB-audited financial statements for fiscal 2025 and audited financial statements for fiscal 2024, prepared under U.S. GAAP and suitable for SEC filings, before closing or as required.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polomar Health Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023937), on May 15, 2026, and is solely responsible for the information contained therein.